View in EDS HTML Full Text PDF Full Text

Societal Costs and Efficiency of Subcutaneous versus Intravenous Lecanemab in Early Alzheimer's Disease: A U.S. Cost Comparison Model.

Saved in:
Bibliographic Details
Title: Societal Costs and Efficiency of Subcutaneous versus Intravenous Lecanemab in Early Alzheimer's Disease: A U.S. Cost Comparison Model.
Authors: Tahami Monfared, Amir Abbas1,2 (AUTHOR) amir_tahami@eisai.com, Barrows, Stephanie3 (AUTHOR) smbarrows523@gmail.com, Fox, Lindsey3 (AUTHOR) lfox@rti.org, Herbel, Brittney3 (AUTHOR) bherbel@rti.org, Herring, William L.3,4 (AUTHOR) wherring@rti.org, Krumbach, Alisha3 (AUTHOR) akrumbach@rti.org, Zhang, Quanwu1 (AUTHOR) quanwu_zhang@eisai.com
Source: Neurology & Therapy. Oct2025, Vol. 14 Issue 5, p1863-1888. 26p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21938253
DOI:10.1007/s40120-025-00790-2